The Point of Care Diagnostics Market growth is driven by factors like rapid increase of highly infectious diseases. POC tests can greatly improve the management of infectious diseases in developing countries where access to timely medical care is a challenge and healthcare infrastructure is sparse. The prevalence of HIV is likely to boost the demand for point-of care diagnostics and further accelerating the treatment of HIV infection. There have been millions of cases for many infectious diseases like respiratory, cardiovascular, HIV/AIDS diseases which have all led to the increase in demand for POC tests. These number of cases are expected to increase due to the consumption of unhealthy diet, low immunity levels, increase in pollution. In order to curb this outbreak of infectious diseases worldwide the healthcare sector authorities are authorizing the use of Point-of Care tests, clinics & centers due to these measures the POC market is growing rapidly. Moreover, this outbreak of diseases has been increasing which significantly contributes to the market’s growth
According to Marketlook Consulting’ research report “Global Point-of-Care Diagnostics Market Analysis, 2021”, the Global Point of Care Diagnostics market is anticipated to grow at a CAGR 9.08% during 2022-29. The market would reach to USD 76.22 billion by 2029.
Based on the product, the POC market is segmented into Cardio-metabolic Monitoring Kit, Glucose Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Haematology Testing, Cholesterol Test Strip, Other Products. The highest market share is held by the infectious diabetes kit as these are available over-the counter without prescription and help the patient in self testing and monitoring their glucose levels. These kits are highly preferrable thus increasing the products sales which in turn leads to the growth of the POC Diagnostics Market.
Basis on end user, the market is segmented into Hospitals & Critical Care Setting, Ambulatory Care Setting, Research Laboratory, Others. Hospitals & Clinic segment has accounted for largest revenue share for the market. The rising access to novel diagnostic technologies, improving healthcare coverage, and affordability are some of the key factors contributing to the growth of the market.
REQUEST FOR SAMPLE:- https://www.marketlookconsulting.com/sample-request/942
“Global POC Diagnostics Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for POC Diagnostics tests providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.
North America Dominated the Market
Based on Leading regions, North America dominated the global market in 2021 and is projected to maintain its dominance during the forecasted period 2022-29. The growth of POC Diagnostics Market is driven by growing illness prevailing, demand for improved healthcare facilities, quick diagnostics services, clinical laboratory staff shortages. The North America Point-of- Care Diagnostics Market provides substantial for both potential and new manufacturers. The market is growing due to technological advances in POC devices, rising prevalence of infectious diseases & increasing expenditure by the major companies. Forthcoming period as stated in Marketlook Consulting research report “Global Point-of Care Diagnostics Market Analysis, 2021”.
According to Marketlook Consulting’, the key players with a considerable market share in the global Air Purifier market are Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson and Company, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Qiagen Inc., Danaher Corporation (Beckman Coulter Inc.), Biomeriux, Instrumentation Laboratory, Nova Biomedical
Market Segmentation:
- By Product (Cardio-metabolic Monitoring Kit, Glucose Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Hematology Testing, Cholesterol Test Strip, Others)
- By End Users (Hospital & Critical Care Setting, Ambulatory Care Setting, Research Laboratory, Others)
- By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)
- By Company (Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson and Company, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Qiagen Inc., Danaher Corporation (Beckman Coulter Inc.), Biomeriux, Instrumentation Laboratory, Nova Biomedical.)
Key questions answered in the study:
- What are the current and future trends of the Point-of Care Diagnostics industry?
- How the industry has been evolving in terms of product demand and end-user areas?
- How the competition has been shaping across the countries followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the Point-of Care Diagnostics industry?
- What is the customer orientation, purchase behavior, and expectations from the Point-of-Care Diagnostics firms across various regions?
READ MORE:- https://www.marketlookconsulting.com/reports/point-of-care-diagnostics-market
About Us:-
Marketlook Consulting is a world market intelligence and consulting firm that aims to offer business insights and market research reports to large as well as small & medium scale enterprises (SMEs). The company helps its clients to design business strategies and policies and accomplish sustainable growth in their relevant market area.
Contact US:-
Phone:- +91 9660950683
Name:- Mithun Jangir (Manager- Marketing & Communications)
Email:- [email protected]
Linkedin:- https://www.linkedin.com/company/marketlook-consulting/
Address:- U 26C/6, DLF Phase 3, Gurgaon 122002
